A Study to Investigate the Safety and Efficacy of YY003 in Adults with Moderate to Severe Glabellar Lines

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Australia

St George Dermatology & Skin Cancer Centre, Sydney, New South Wales

Skin Health Institute, Melbourne, Victoria

Dermatology Institute of Victoria, Melbourne, Victoria